LabCompass

Magdalena Korecka

Medicine · Indiana University

Publications

192

Citations

14,373

Est. group size

Recurring co-author estimate

Active years

61

Publishing since 1966

Research summary
AI-generated

Magdalena Korecka's research focuses on developing and validating laboratory methods to detect and measure biomarkers of Alzheimer's disease, such as amyloid-beta and tau proteins, in blood plasma and cerebrospinal fluid. A major thread is moving from invasive spinal-fluid tests toward reliable blood-based tests using techniques like mass spectrometry. Much of this work supports large multi-site studies and clinical trials, including efforts to compare biomarker performance across different racial groups and to monitor patients' responses to anti-amyloid therapies.

Alzheimer's disease blood and cerebrospinal fluid biomarkersMass spectrometry and analytical laboratory methodsBiomarker validation and standardizationDisease staging and clinical trajectory modelingMulti-site clinical research infrastructure (e.g., ADNI)

Publication activity has been steady over the past decade, averaging roughly seven to eight papers per year with a notable peak in 2020 and continued strong output in 2025.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 7.0/year recently
2017: 8 publications172018: 5 publications182019: 10 publications192020: 14 publications14202021: 9 publications212022: 8 publications222023: 6 publications232024: 8 publications242025: 11 publications252026: 2 publications26
Recent publications
Publishes in
  • Scientific Reports×17
  • Alzheimer s & Dementia×17
  • Nature Communications×14
  • Neurology×12
  • GeroScience×8

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile